{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:21:55Z","timestamp":1788308515405,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Public Health"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00038-020-01391-6","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T02:02:43Z","timestamp":1591236163000},"page":"683-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia"],"prefix":"10.1007","volume":"65","author":[{"name":"Eastern Slovakia PBC Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-6757","authenticated-orcid":false,"given":"Sylvia","family":"Drazilova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-1180","authenticated-orcid":false,"given":"Ingrid","family":"Babinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-2217","authenticated-orcid":false,"given":"Jakub","family":"Gazda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Halanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3329-3968","authenticated-orcid":false,"given":"Martin","family":"Janicko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"Kucinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Safcak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Martinkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Tarbajova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cekanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-9984","authenticated-orcid":false,"given":"Peter","family":"Jarcuska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"1391_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/HMER.S25998","volume":"4","author":"N Al-Harthy","year":"2012","unstructured":"Al-Harthy N, Kumagi T (2012) Natural history and management of primary biliary cirrhosis. Hepatol Med 4:61\u201371. \nhttps:\/\/doi.org\/10.2147\/HMER.S25998","journal-title":"Hepatol Med"},{"key":"1391_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","volume":"19","author":"P Angulo","year":"1999","unstructured":"Angulo P, Lindor KD, Therneau TM et al (1999) Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 19:115\u2013121. \nhttps:\/\/doi.org\/10.1111\/j.1478-3231.1999.tb00020.x","journal-title":"Liver"},{"key":"1391_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 56:1181\u20131188. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2011.10.025","journal-title":"J Hepatol"},{"key":"1391_CR4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S et al (2016) The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology 63:930\u2013950. \nhttps:\/\/doi.org\/10.1002\/hep.28017","journal-title":"Hepatology"},{"key":"1391_CR5","first-page":"622","volume":"9","author":"VH Chong","year":"2010","unstructured":"Chong VH, Telisinghe PU, Jalihal A (2010) Primary biliary cirrhosis in Brunei Darussalam Hepatobiliary Pancreat. Dis Int 9:622\u2013628","journal-title":"Dis Int"},{"key":"1391_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N et al (2008) Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48:871\u2013877. \nhttps:\/\/doi.org\/10.1002\/hep.22428","journal-title":"Hepatology"},{"key":"1391_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","volume":"53","author":"C Corpechot","year":"2010","unstructured":"Corpechot C, Chretien Y, Chazouilleres O et al (2010) Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53:162\u2013169. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2010.02.019","journal-title":"J Hepatol"},{"key":"1391_CR8","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouilleres O, Poupon R (2011) Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol 55:1361\u20131367. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2011.02.031","journal-title":"J Hepatol"},{"key":"1391_CR9","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","volume":"378","author":"C Corpechot","year":"2018","unstructured":"Corpechot C, Chazouilleres O, Rousseau A et al (2018) A placebo-controlled trial of bezafibrate in primary biliary cholangitis. N Engl J Med 378:2171\u20132181. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1714519","journal-title":"N Engl J Med"},{"key":"1391_CR10","first-page":"717","volume":"7","author":"J Delgado","year":"2005","unstructured":"Delgado J, Sperber AD, Novack V et al (2005) The epidemiology of primary biliary cirrhosis in southern Israel. Isr Med Assoc J 7:717\u2013721","journal-title":"Isr Med Assoc J"},{"key":"1391_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver, Electronic address eee, European Association for the Study of the L (2017) EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67:145\u2013172. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2017.03.022","journal-title":"J Hepatol"},{"key":"1391_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-230x-12-92","volume":"12","author":"P Invernizzi","year":"2012","unstructured":"Invernizzi P, Alessio MG, Smyk DS et al (2012) Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol 12:92. \nhttps:\/\/doi.org\/10.1186\/1471-230x-12-92","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 2","key":"1391_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000440705","volume":"33","author":"P Jepsen","year":"2015","unstructured":"Jepsen P, Gronbaek L, Vilstrup H (2015) Worldwide incidence of autoimmune liver disease. Dig Dis 33(Suppl 2):2\u201312. \nhttps:\/\/doi.org\/10.1159\/000440705","journal-title":"Dig Dis"},{"key":"1391_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/gut.36.6.935","volume":"36","author":"RA Jorgensen","year":"1995","unstructured":"Jorgensen RA, Dickson ER, Hofmann AF et al (1995) Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut 36:935\u2013938. \nhttps:\/\/doi.org\/10.1136\/gut.36.6.935","journal-title":"Gut"},{"key":"1391_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/apt.13448","volume":"43","author":"KA Kim","year":"2016","unstructured":"Kim KA, Ki M, Choi HY et al (2016) Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther 43:154\u2013162. \nhttps:\/\/doi.org\/10.1111\/apt.13448","journal-title":"Aliment Pharmacol Ther"},{"key":"1391_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/DMA-2010-0769","volume":"29","author":"E Kouroumalis","year":"2010","unstructured":"Kouroumalis E (2010) Environmental agents involved in the cause of primary biliary cirrhosis. Dis Markers 29:329\u2013336. \nhttps:\/\/doi.org\/10.3233\/DMA-2010-0769","journal-title":"Dis Markers"},{"key":"1391_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper EM, Hansen BE, de Vries RA et al (2009) Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 136:1281\u20131287. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2009.01.003","journal-title":"Gastroenterology"},{"key":"1391_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE et al (2010) Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol 105:2186\u20132194. \nhttps:\/\/doi.org\/10.1038\/ajg.2010.216","journal-title":"Am J Gastroenterol"},{"issue":"1804\u20131812","key":"1391_CR19","doi-asserted-by":"publisher","first-page":"e1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C et al (2015) Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology 149(1804\u20131812):e1804. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2015.07.061","journal-title":"Gastroenterology"},{"key":"1391_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2018","unstructured":"Lindor KD, Bowlus CL, Boyer J et al (2018) Primary biliary cholangitis. Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 69:394\u2013419. \nhttps:\/\/doi.org\/10.1002\/hep.30145","journal-title":"Hepatology"},{"key":"1391_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1471-230X-10-100","volume":"10","author":"H Liu","year":"2010","unstructured":"Liu H, Liu Y, Wang L et al (2010) Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol 10:100. \nhttps:\/\/doi.org\/10.1186\/1471-230X-10-100","journal-title":"BMC Gastroenterol"},{"key":"1391_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/hep.24630","volume":"55","author":"A Lleo","year":"2012","unstructured":"Lleo A, Liao J, Invernizzi P et al (2012) Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 55:153\u2013160. \nhttps:\/\/doi.org\/10.1002\/hep.24630","journal-title":"Hepatology"},{"issue":"1342\u20131350","key":"1391_CR23","doi-asserted-by":"publisher","first-page":"e1341","DOI":"10.1016\/j.cgh.2017.12.033","volume":"16","author":"M Lu","year":"2018","unstructured":"Lu M, Zhou Y, Haller IV et al (2018) Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment. Clin Gastroenterol Hepatol 16(1342\u20131350):e1341. \nhttps:\/\/doi.org\/10.1016\/j.cgh.2017.12.033","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1391_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3325\/cmj.2019.60.494","volume":"60","author":"A Madir","year":"2019","unstructured":"Madir A, Bozin T, Mikolasevic I et al (2019) Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study. Croat Med J 60:494\u2013502","journal-title":"Croat Med J"},{"key":"1391_CR25","doi-asserted-by":"publisher","first-page":"11525","DOI":"10.1038\/s41598-019-47890-2","volume":"9","author":"HU Marschall","year":"2019","unstructured":"Marschall HU, Henriksson I, Lindberg S et al (2019) Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Sci Rep 9:11525. \nhttps:\/\/doi.org\/10.1038\/s41598-019-47890-2","journal-title":"Sci Rep"},{"key":"1391_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G et al (2016) A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med 375:631\u2013643. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1509840","journal-title":"N Engl J Med"},{"key":"1391_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 130:715\u2013720. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2005.12.029","journal-title":"Gastroenterology"},{"key":"1391_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/meg.0b013e328277594a","volume":"19","author":"X Pla","year":"2007","unstructured":"Pla X, Vergara M, Gil M et al (2007) Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Eur J Gastroenterol Hepatol 19:859\u2013864. \nhttps:\/\/doi.org\/10.1097\/meg.0b013e328277594a","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1391_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.4254\/wjh.v7.i7.926","volume":"7","author":"T Purohit","year":"2015","unstructured":"Purohit T, Cappell MS (2015) Primary biliary cirrhosis: pathophysiology, clinical presentation and therapy. World J Hepatol 7:926\u2013941. \nhttps:\/\/doi.org\/10.4254\/wjh.v7.i7.926","journal-title":"World J Hepatol"},{"key":"1391_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.clinre.2015.10.006","volume":"40","author":"J Raszeja-Wyszomirska","year":"2016","unstructured":"Raszeja-Wyszomirska J, Wunsch E, Krawczyk M et al (2016) Assessment of health related quality of life in polish patients with primary biliary cirrhosis. Clin Res Hepatol Gastroenterol 40:471\u2013479. \nhttps:\/\/doi.org\/10.1016\/j.clinre.2015.10.006","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1391_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2188\/jea.15.24","volume":"15","author":"F Sakauchi","year":"2005","unstructured":"Sakauchi F, Mori M, Zeniya M et al (2005) A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 15:24\u201328. \nhttps:\/\/doi.org\/10.2188\/jea.15.24","journal-title":"J Epidemiol"},{"key":"1391_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12072-016-9767-9","volume":"10","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Ma X, Yokosuka O et al (2016) Autoimmune liver diseases in the Asia-Pacific region: proceedings of APASL symposium on AIH and PBC 2016. Hepatol Int 10:909\u2013915. \nhttps:\/\/doi.org\/10.1007\/s12072-016-9767-9","journal-title":"Hepatol Int"},{"key":"1391_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/hep.26322","volume":"58","author":"LN Zhang","year":"2013","unstructured":"Zhang LN, Shi TY, Shi XH et al (2013) Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study. Hepatology 58:264\u2013272. \nhttps:\/\/doi.org\/10.1002\/hep.26322","journal-title":"Hepatology"},{"key":"1391_CR34","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.3748\/wjg.v21.i12.3554","volume":"21","author":"XX Zhang","year":"2015","unstructured":"Zhang XX, Wang LF, Jin L et al (2015) Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors. World J Gastroenterol 21:3554\u20133563. \nhttps:\/\/doi.org\/10.3748\/wjg.v21.i12.3554","journal-title":"World J Gastroenterol"}],"container-title":["International Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00038-020-01391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00038-020-01391-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00038-020-01391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T22:13:49Z","timestamp":1594764829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00038-020-01391-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1391"],"URL":"https:\/\/doi.org\/10.1007\/s00038-020-01391-6","relation":{},"ISSN":["1661-8556","1661-8564"],"issn-type":[{"value":"1661-8556","type":"print"},{"value":"1661-8564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol is in accordance with the 1964 Helsinki Declaration and its later amendments and was approved by the Ethical committee of Poprad Hospital, a.s., on May 5, 2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}